valine has been researched along with phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouairi, E; Evans, C; Gold, A; Griffioen, KJ; Huang, ZG; Mendelowitz, D; Venkatesan, P; Wang, X | 1 |
1 other study(ies) available for valine and phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide
| Article | Year |
|---|---|
Fentanyl inhibits GABAergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Anesthetics, Local; Animals; Animals, Newborn; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fentanyl; gamma-Aminobutyric Acid; Glycine Agents; Heart; In Vitro Techniques; Medulla Oblongata; Membrane Potentials; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Somatostatin; Strychnine; Synaptic Transmission; Tetrodotoxin; Vagus Nerve; Valine | 2004 |